Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis
Status:
Not yet recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of intravenous SHR-1906 in the treatment of idiopathic
pulmonary fibrosis. The study is divided into four stages: screening period, baseline period,
treatment period and safe follow-up period. It is planned that 108 patients will be randomly
assigned to the following three treatment groups for treatment